ACM
TNDM icon

AlphaCrest Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

AlphaCrest Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,989
Closed -$334K – 1041
2022
Q3 		$334K Sell
6,989
-5,351
-43% -$293K 0.02% 1117
2022
Q2 		$730K Sell
12,340
-1,811
-13% -$149K 0.04% 809
2022
Q1 		$1.65M Buy
14,151
+7,030
+99% +$821K 0.09% 317
2021
Q4 		$1.07M Sell
7,121
-5,039
-41% -$680K 0.04% 758
2021
Q3 		$1.45M Sell
12,160
-296
-2% -$32.6K 0.08% 440
2021
Q2 		$1.21M Buy
12,456
+2,256
+22% +$201K 0.05% 570
2021
Q1 		$900K Buy
10,200
+6,158
+152% +$572K 0.05% 540
2020
Q4 		$387K Sell
4,042
-2,776
-41% -$286K 0.03% 796
2020
Q3 		$774K Buy
+6,818
New +$716K 0.08% 365
2020
Q2 		– Sell
-11,100
Closed -$714K – 1119
2020
Q1 		$714K Buy
11,100
+6,800
+158% +$476K 0.09% 415
2019
Q4 		$256K Sell
4,300
-5,800
-57% -$358K 0.02% 1137
2019
Q3 		$596K Buy
+10,100
New +$645K 0.04% 828

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AlphaCrest Capital Management's TNDM Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Tandem Diabetes Care (TNDM) in Q4 2022, closing a stake of 6,989 shares — an estimated $334K sold.

AlphaCrest Capital Management first reported a position in TNDM in Q3 2019 and held it in 12 quarters. The position peaked at $1.65M in Q1 2022. 295 funds tracked by Wall St. Rank hold TNDM as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Tandem Diabetes Care position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 6,989 Tandem Diabetes Care shares in Q4 2022, an estimated $334K.
  • AlphaCrest Capital Management first reported a position in Tandem Diabetes Care in Q3 2019 and held it in 12 quarters.
  • AlphaCrest Capital Management's Tandem Diabetes Care position peaked at $1.65M in Q1 2022.
  • 295 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.